期刊档案 · PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
International Journal of Risk & Safety in Medicine
ISSN 0924-6479 · eISSN 1878-6847 · SAGE Publications (formerly IOS Press)
International Journal of Risk & Safety in Medicine 中科院 医学 4区(2025 年升级版),影响因子 0.9(官网公布),混合开放获取,APC 约 3,900 美元,2025 年发文 67 篇,ESCI、Scopus 收录。
研究范围
研究范围与定位
International Journal of Risk & Safety in Medicine 由 SAGE Publications (formerly IOS Press) 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Pharmacovigilance and Adverse Drug Reactions、Pharmaceutical Economics and Policy、Medical Malpractice and Liability Issues 等主题的论文,这 3 个主题约占 27.6%,主导子领域为 Economics and Econometrics。(根据 OpenAlex 主题统计与中科院分区数据生成)
The International Journal of Risk & Safety in Medicine: Patient Safety - Pharmacovigilance – Liability is concerned with rendering the practice of medicine as safe as it can be; that involves promoting the highest possible quality of care, but also examining how those risks, which are inevitable, can be contained and managed ideally... View full journal description
摘自期刊官网 Aims & Scope
研究方向(LetPub):PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
主编 Liliya E. Ziganshina出版商官网
编委会国家分布:未见中国大陆编委;主要国家 美国 3、英国 3、意大利 3、尼日利亚 3、荷兰 2(共 23 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics10.7%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance8.6%
- Medical Malpractice and Liability IssuesHealth Professions8.4%
- Patient Safety and Medication ErrorsHealth Professions8.3%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics6.2%
- Pharmaceutical studies and practicesMedicine6.2%
- Human auditory perception and evaluationEngineering5.6%
- Pharmaceutical Practices and Patient OutcomesMedicine5.4%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 公共卫生、环境卫生与职业卫生PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 4 区 |
Top 期刊:否综述期刊:否
《新锐期刊分区表》( 2026年3月发布)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 公共卫生、环境卫生与职业卫生PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 4 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子(出版商公布)
- 0.9出版商官网 ·
- 五年影响因子(出版商公布)
- 1出版商官网 ·
- CiteScore 2026-06
- 2LetPub ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 224OpenAlex ·
- 两年平均被引
- 1.01OpenAlex ·
- 自引率
- 11.1%LetPub ·
- Gold OA 文章占比
- 5.17%LetPub ·
发文规模
- 年文章数
- 56LetPub ·
- 年发文量(出版商公布)
- 3出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 1,362 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 43 | 7 | 15 |
| 2025 | 67 | 20 | 67 |
| 2024 | 30 | 10 | 60 |
| 2023 | 28 | 15 | 86 |
| 2022 | 52 | 35 | 127 |
| 2021 | 32 | 10 | 260 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 评审方式
- 单盲同行评审、开放同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,900 / GBP 2,859 | — | — | |
| 出版商官网 | 有,金额未公布 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点8 项,摘自作者指南
- 摘要
- ≤ 200 词
- 正文篇幅
- ≤ 5,500 词
- 参考文献格式
- Vancouver 格式
- 首次投稿格式
- 允许不按期刊格式排版(free format)
- 推荐审稿人
- 可选
- Highlights(研究亮点)
- 可选
- 图文摘要
- 可选
- 投稿信(Cover letter)
- 必须提供
接收的文章类型15 种,含篇幅限制
- book reviewResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- book reviewsBook reviews: Book reviews should be 750 words or less and without sections.未说明篇幅
- brief reportResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…正文 ≤ 1,500 词
- brief reportsBrief reports: Brief reports are articles of original scholarship of unusual interest of less than 1500 words (not including references). They should be structu…未说明篇幅
- case reportResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…正文 ≤ 2,000 词
- case reportsCase reports: Case reports explain the diagnosis, treatment, and outcome of an individual case which has not been previously published in the medical literature…未说明篇幅
- commentariesCommentaries: Commentaries are short opinion pieces representing the author’s viewpoint. Commentaries should be 1000 words or less with an abstract and no other…未说明篇幅
- commentaryResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…正文 ≤ 1,000 词
- opinionResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- perspectiveResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- research articleResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- reviewResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- review articleResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- systematic reviewResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
- viewpointResearch articles: Research articles should present novel work within the scope of the journal which represents an important advancement in knowledge or underst…未说明篇幅
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- 作者资格 Author contributions
该期刊要求在提交过程中列出每位作者的贡献,并在提交稿件的致谢部分之后包含作者贡献标题。 模型中文摘要
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
原文 ↗出版商官网 ·- 数据可用性 Data availability
该期刊鼓励作者在符合伦理和法律要求的前提下,将研究数据存储在公共数据仓库中,并包含数据可用性声明。 模型中文摘要
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
原文 ↗出版商官网 ·- 出版伦理 Ethical considerations
该期刊要求所有涉及人类参与者、人类数据或人体组织的研究必须声明获得相关伦理委员会或机构审查委员会的批准,或豁免批准。 模型中文摘要
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
原文 ↗出版商官网 ·- 开放获取 Publishing fees and open access
该期刊不收取提交或出版费用,但可选的开放获取出版可通过Sage Choice计划或开放获取协议付费进行。 模型中文摘要
There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. If you wish to have color figures in the printed version, fees will be determined and applied at production stage. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where …
原文 ↗出版商官网 ·- 同行评审 Peer review policy
该期刊采用单盲同行评审政策,审稿人姓名对提交作者保密。 模型中文摘要
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: Review reportsAuthor/editor communicationReviewer identities (reviewer opt in) Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned…
原文 ↗出版商官网 ·- 查重 Plagiarism
该期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题。 模型中文摘要
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
原文 ↗出版商官网 ·- 预印本 Preprints
该期刊接受已在预印本服务器上发布的稿件,但要求在提交时输入预印本DOI,并建议在同行评审期间不要在预印本服务器上发布更新版本。 模型中文摘要
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical trial registration
该期刊支持ICMJE要求,即临床试验在首次参与者入组时或之前在WHO批准的公共试验注册中心注册。 模型中文摘要
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- SAGE Publications (formerly IOS Press)
- ISSN
- 0924-6479
- 电子版 ISSN
- 1878-6847
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗出版商官网
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 International Journal of Risk & Safety in Medicine 的常见问题
International Journal of Risk & Safety in Medicine 是中科院几区期刊?
2025 年升级版分区表中,International Journal of Risk & Safety in Medicine 为医学 4区,小类 公共卫生、环境卫生与职业卫生 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
International Journal of Risk & Safety in Medicine 的影响因子是多少?
期刊官网公布的影响因子为 0.9,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 2,h-index 为 38。
International Journal of Risk & Safety in Medicine 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 200 词;正文篇幅:≤ 5,500 词;参考文献格式:Vancouver 格式;首次投稿格式:允许不按期刊格式排版(free format);推荐审稿人:可选;Highlights:可选;图文摘要:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
International Journal of Risk & Safety in Medicine 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 23 位编委中,没有中国大陆学者;人数最多的国家是 美国(3 位)、英国(3 位)、意大利(3 位)。统计按编委会页面列出的机构国家计,仅供参考。
International Journal of Risk & Safety in Medicine 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,International Journal of Risk & Safety in Medicine 被 ESCI、Scopus 收录。
International Journal of Risk & Safety in Medicine 是开放获取期刊吗?版面费多少?
International Journal of Risk & Safety in Medicine 为混合开放获取。选择开放获取发表时APC 约 3,900 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-30 归档)。最近更新:。